Published on


Ophthalmology – Blepharospasm and Hemifacial Spasm




Blepharospasm and hemifacial spasm are movement disorders involving involuntary contractions of facial muscles. Blepharospasm refers to bilateral, involuntary eyelid closure due to spasms of the eyelid muscles, while hemifacial spasm involves unilateral contractions of muscles supplied by the facial nerve. These conditions primarily affect the nervous and musculoskeletal systems and are most commonly seen in middle-aged adults, with a higher prevalence in women.


Blepharospasm may be classified as essential (idiopathic), associated with dystonia (such as Meige syndrome, which involves the face, jaw, and neck), or secondary to ocular irritation such as dry eye or inflammation. Hemifacial spasm, on the other hand, is typically caused by vascular compression of the facial nerve, although rarely tumors in the posterior fossa may be responsible.


The pathophysiology of blepharospasm involves abnormal simultaneous contraction of opposing muscle groups: the eyelid protractors (such as the orbicularis oculi) and retractors (such as the levator palpebrae). There may also be increased sensitivity of the trigeminal system, particularly in patients with photophobia. In hemifacial spasm, abnormal nerve transmission (ephaptic transmission) occurs due to irritation or compression of the facial nerve, leading to synchronous contractions of facial muscles.


Clinically, patients with blepharospasm initially experience increased blinking, which progresses to involuntary, forceful eyelid closure that may become disabling. Symptoms may begin unilaterally but usually become bilateral. Ocular irritation is often present. In hemifacial spasm, patients develop intermittent twitching around one eye that gradually spreads to involve other muscles on the same side of the face. These spasms are typically synchronous and persist during sleep in some cases.


On examination, blepharospasm is characterized by nonvolitional contraction of multiple eyelid muscles, not just the orbicularis. It is important to exclude underlying ocular causes such as dry eye or eyelid abnormalities. Hemifacial spasm presents with coordinated, unilateral contractions of facial muscles. Neuroimaging, particularly MRI or MRA of the brain with attention to the posterior fossa, is recommended to evaluate for vascular compression or other structural causes.


Treatment focuses on symptom control. Botulinum toxin injections are the first-line therapy for both conditions and are highly effective, with about 90% of patients experiencing improvement. These injections are typically administered every 3–4 months. Oral medications such as carbamazepine, baclofen, or clonazepam may be used but are often less effective and can cause sedation. In cases of hemifacial spasm due to vascular compression, microvascular decompression surgery may be considered. Surgical options for blepharospasm, such as orbicularis myectomy, are reserved for refractory cases.


Regular follow-up is important, especially after botulinum injections, to assess response and determine the timing of repeat treatment. Patients should be educated about the chronic nature of these conditions and reassured that effective treatment options are available. Reducing triggers such as stress or excessive caffeine intake may help in some cases.


The prognosis is generally favorable, particularly with botulinum toxin therapy. However, untreated or severe cases can significantly impact quality of life due to functional visual impairment. Surgical interventions, while effective in selected cases, carry risks such as facial weakness or hearing loss, particularly in procedures involving the facial nerve.

​
Picture
0 Comments